Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS)
CNY 5.32
(-0.56%)
CNY 5.32
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 98.83 Million | -124.4 Million | 99.65 Million | 73.42 Million | 43.7 Million | 119.46 Million |
| Net Income | 43.55 Million | -75.71 Million | 6.77 Million | 27.59 Million | 44.96 Million | -115.45 Million |
| Depreciation & Amortization | 75.69 Million | 62.98 Million | 57.18 Million | 41.42 Million | 39.43 Million | 51.29 Million |
| Deferred income taxes | -6.75 Million | -11.56 Million | -6.76 Million | -3.15 Million | -4.57 Million | -11.14 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -133.72 Million | -230.87 Million | -92.19 Million | -87.56 Million | -134.23 Million | -47.63 Million |
| Other non-cash items | 405.17 Million | 119.19 Million | 127.89 Million | 91.97 Million | 93.53 Million | 231.26 Million |
| Investing Cash Flow | -205.11 Million | 134.11 Million | -100.15 Million | -188.84 Million | -78.73 Million | -83.8 Million |
| Investments in PPE | -43.13 Million | -66.62 Million | -39.07 Million | -72.65 Million | -107.67 Million | -66.4 Million |
| Acquisitions | 2.01 Million | 200 Thousand | 570 Thousand | 79.27 Thousand | 27.11 Million | 11.85 Million |
| Investment purchases | -697.41 Million | -1.21 Billion | -805.48 Million | -1.6 Billion | -457.1 Million | -215.6 Million |
| Sales/Maturities of investments | 533.4 Million | 1.41 Billion | 720.87 Million | 1.49 Billion | 458.82 Million | 186.33 Million |
| Other Investing Activities | 1.00 | 191.38 Thousand | 22.95 Million | 1.8 Million | 100.22 Thousand | 5000.96 |
| Financing Cash Flow | 26.56 Million | -85.22 Million | -156.58 Million | 209.57 Million | -240.88 Million | 64.29 Million |
| Debt repayment | -135.58 Million | -1.16 Billion | -1.29 Billion | -852.71 Million | -911.8 Million | -671.95 Million |
| Dividends payments | -50.16 Million | -5.63 Million | -9 Million | -65.46 Million | -59.98 Million | -66.99 Million |
| Common Stock Repurchased | -76.81 Million | -125.75 Million | -45.47 Million | -26.82 Million | -126.3 Million | -1.1 Million |
| Common Stock Issuance | 34.46 Million | 137.16 Million | 95.15 Million | 26.82 Million | 126.3 Million | - |
| Other Financing Activities | 254.67 Million | 1.13 Billion | 1.17 Billion | 1.12 Billion | 730.89 Million | 803.23 Million |
| Accounts receivables | -3.06 Million | -380.27 Million | -130.93 Million | -9.23 Million | -123.92 Million | -92.5 Million |
| Accounts payables | -123.27 Million | 231.57 Million | 82.79 Million | -23.82 Million | 556.58 Thousand | 114.63 Million |
| Inventory | -7.38 Million | -70.6 Million | -37.3 Million | -51.35 Million | -8.97 Million | -58.62 Million |
| Other working capital | -1.00 | -11.56 Million | -6.76 Million | -3.15 Million | -1.88 Million | 10.99 Million |
| Cash at beginning of period | 311.38 Million | 330.23 Million | 487.31 Million | 393.16 Million | 669 Million | 569.05 Million |
| Cash at end of period | 196.66 Million | 254.72 Million | 330.23 Million | 487.31 Million | 393.09 Million | 669 Million |
| Capital Expenditure | -43.13 Million | -66.62 Million | -39.07 Million | -72.65 Million | -107.67 Million | -66.4 Million |
| Effect of forex changes on cash | -35 Million | 0.69 | 0.11 | 0.59 | 0.36 | 0.77 |
| Net cash flow / Change in cash | -114.71 Million | -75.51 Million | -157.08 Million | 94.15 Million | -275.91 Million | 99.95 Million |
| Free Cash Flow | 55.7 Million | -191.02 Million | 60.58 Million | 774.92 Thousand | -63.97 Million | 53.06 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.27 Million | 5.35 Million | 21.25 Million | 60.48 Million | 43.55 Million | 21.4 Million |
| Depreciation & Amortization | - | 19.02 Million | 19.04 Million | 18.49 Million | 75.69 Million | -34.66 Million |
| Deferred income taxes | - | - | - | - | -6.75 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -37.45 Million | - | -10.45 Million | -133.72 Million | -25.91 Million |
| Other non-cash items | -5.98 Million | 38.44 Million | -136.61 Million | 28.23 Million | 405.17 Million | 104.53 Million |
| Investing Cash Flow | 416.71 Thousand | -5.64 Million | 100.27 Million | -113.78 Million | -205.11 Million | 22.34 Million |
| Investments in PPE | -2.12 Million | -3.83 Million | -3.47 Million | -13.55 Million | -43.13 Million | -11.58 Million |
| Acquisitions | -3.24 Million | 3.26 Million | 137.61 Thousand | 816.02 Thousand | 2.01 Million | 450 Thousand |
| Investment purchases | -73.3 Million | -112.84 Million | -213.71 Million | -257.94 Million | -697.41 Million | -248.48 Million |
| Sales/Maturities of investments | 75.84 Million | 107.78 Million | 317.32 Million | 156.9 Million | 533.4 Million | 281.84 Million |
| Other Investing Activities | 4700.00 | -4.14 Million | 103.74 Million | -1.00 | 1.00 | 121.44 Thousand |
| Financing Cash Flow | 50.06 Million | 59.23 Million | 45.89 Million | 45.71 Million | 26.56 Million | -52.25 Million |
| Debt repayment | -59.41 Million | -91.57 Million | -94.74 Million | -147.33 Million | -135.58 Million | -107.5 Million |
| Dividends payments | -26 Million | -15.43 Million | -12.06 Million | -17.48 Million | -50.16 Million | -11.37 Million |
| Common Stock Repurchased | 21.28 Million | -21.28 Million | - | -76.81 Million | -76.81 Million | 42.12 Million |
| Common Stock Issuance | - | - | - | 34.46 Million | 34.46 Million | -58.22 Thousand |
| Other Financing Activities | 16.64 Million | -1.91 Million | -36.78 Million | 252.87 Million | 254.67 Million | 24.54 Million |
| Accounts receivables | - | 550.51 Thousand | - | -3.06 Million | -3.06 Million | -33.85 Million |
| Accounts payables | - | - | - | - | -123.27 Million | - |
| Inventory | - | -38 Million | - | -7.38 Million | -7.38 Million | 7.94 Million |
| Other working capital | - | - | - | - | -1.00 | - |
| Cash at beginning of period | 283.72 Million | 284.93 Million | 182.92 Million | 181.54 Million | 311.38 Million | 140.91 Million |
| Cash at end of period | 329.44 Million | 325.39 Million | 213.27 Million | 196.66 Million | 196.66 Million | 146.31 Million |
| Capital Expenditure | -2.12 Million | -3.83 Million | -3.47 Million | -13.55 Million | -43.13 Million | -11.58 Million |
| Effect of forex changes on cash | - | - | - | -13.56 Million | -35 Million | -30.05 Million |
| Net cash flow / Change in cash | 45.71 Million | 40.45 Million | 30.34 Million | 15.11 Million | -114.71 Million | 5.39 Million |
| Free Cash Flow | -5.83 Million | 20.94 Million | -118.82 Million | 83.21 Million | 55.7 Million | 53.77 Million |
EMIL-PREF
MDI
CNNRF
MAGNAELQ
ALUR
CHGZ